American Regent announced the voluntary recall on July 24, 2026. The FDA published its notice on July 27. The affected product was distributed across the United States beginning September 30, 2025, so hospitals, clinics and other health-care facilities should check their inventories.

How to identify the recalled product

The recall covers only the following product and lot:

• Product: Papaverine Hydrochloride Injection, USP, 60 mg/2 mL
• Format: Single-dose vial
• NDC: 0517-4002-25
• Lot: 25202
• Expiration date: November 30, 2026

The recall does not cover every papaverine injection, every American Regent product or every lot of this medication. Facilities should match the product’s NDC, lot number and expiration date before taking action.

Why the injection was recalled

According to the FDA notice, the particulate matter was identified as glass and/or paraformaldehyde. The agency warns that injecting a product containing particles may cause local irritation or swelling. Particles could also travel through blood vessels to the heart, lungs or brain, potentially causing stroke or death.

The FDA describes those outcomes as potential risks associated with injected particulate matter. American Regent said it had received no related adverse-event reports as of July 24, 2026. That statement does not mean patients should ignore possible symptoms or change treatment without medical advice.

What health-care facilities should do

Hospitals, clinics, procedural settings, pharmacies and other health-care facilities that may have the affected vials should stop using them and isolate the product. American Regent’s instructions call for recalled product to be returned or discarded according to the company’s directions. Facilities should follow the manufacturer’s return, replacement or disposal instructions rather than placing affected vials back into routine inventory.

Papaverine injection is administered by or under the direction of a physician. It may be encountered primarily in health-care settings rather than as a medication that patients routinely keep at home.

What patients should do

Patients who may have received the recalled injection should contact their doctor or health-care provider for individualized guidance, especially if they have concerns or experienced a possible problem after treatment. Patients should not independently stop, restart or change other prescribed treatment without medical advice.

The immediate question for facilities is whether they have lot 25202. Providers and patients should continue to monitor FDA and American Regent updates for additional instructions. This recall concerns one identified lot of an injectable prescription drug, not a medical device or all papaverine products.

Sources

• FDA recall notice
• American Regent recall announcement
• DailyMed Papaverine Hydrochloride Injection label

CDC also says the investigation is still open. If you have the recalled product in your freezer, CDC and FDA guidance is straightforward: do not eat it, and remove it now.

What changed this week (CDC media alert + outbreak tracker)

On July 7, 2026, CDC’s media alert told the public that 12 people in two states have gotten sick from the same E. coli strain linked to frozen blueberries, and it reiterated the immediate household and retailer steps. CDC also warned that some people can develop serious kidney problems related to Shiga toxin-producing E. coli (including hemolytic uremic syndrome, or HUS), which may require hospitalization.

CDC’s outbreak tracker (published July 6, 2026) lists the fast facts as:

• Cases: 12
• Hospitalizations: 4
• Deaths: 0
• States: 2

Which product is involved (check your freezer)

This is not a blanket “frozen blueberries” warning—CDC and FDA are pointing to one recalled product identification.

According to FDA’s recall notice, the affected product is:

• Product: Frozen GreenWise Organic IQF Blueberries
• Package size: 10 oz
• Lot code: 60401
• Best-by date: February 9, 2028
• Recall scope: The product was shipped to Publix retail stores across 8 states (including Alabama, Florida, Georgia, Kentucky, North Carolina, South Carolina, Tennessee, and Virginia).

FDA also states that no other lot codes or Best By dates are affected by this recall.

Symptoms to watch for—and when to seek medical care

CDC says most people infected with Shiga toxin-producing E. coli experience severe stomach cramps, diarrhea (often bloody), and vomiting. Symptoms usually start 3 to 4 days after swallowing the bacteria, and most people recover without treatment after 5 to 7 days.

Call your healthcare provider right away if you have any of these severe E. coli symptoms (as listed by CDC):

• Diarrhea and a fever higher than 102°F
• Diarrhea for more than 3 days that is not improving
• Bloody diarrhea
• So much vomiting that you cannot keep liquids down
• Signs of dehydration, such as:
  • Not peeing much
  • Dry mouth and throat
  • Feeling dizzy when standing up

CDC also cautions that some people may develop serious kidney problems (HUS) that can require hospitalization. Warning clues CDC lists include:

• Decreased frequency of urination
• Feeling very tired
• Loss of pink color in cheeks and inside the lower eyelids

What to do right now (households and retailers)

For households: CDC says not to eat any recalled frozen blueberries. Throw the product away or return it to the place of purchase. CDC also recommends washing items and surfaces that may have touched the recalled blueberries using hot, soapy water or a dishwasher.

For retailers: CDC says businesses should not sell or serve the recalled frozen blueberries and should wash and sanitize items and surfaces that may have come in contact with them. CDC’s investigation update says Publix has stopped selling the affected blueberries at its stores.

What to watch next

CDC’s investigation update (dated July 6, 2026) says public health officials are collecting information from sick people to help investigators identify the outbreak source. Keep an eye on CDC outbreak updates for any changes in case counts, and on FDA recall updates if distribution details are expanded or clarified.

For readers, the immediate action does not depend on new numbers: if your frozen GreenWise blueberries match lot 60401 and the February 9, 2028 best-by date, remove the product from your home now.

Sources

• CDC: Media alert (July 7, 2026)
• FDA: Safety alert / recall notice (publish date July 6, 2026)

What changed (and why it matters)

FDA says the problem involves labeling, not a typical contamination issue: the dairy allergen was not disclosed on some recalled packages. FDA notes no illnesses or injuries have been reported to date that are connected to this issue.

Which packages are affected

Check for both identifiers below:

• Expiration dates: November 2028 through May 2029
• Labeling condition: milk is not listed on the package

Who should act immediately

FDA warns that people with a milk allergy or severe milk sensitivity should not eat the affected product, because an allergic reaction could be serious or life-threatening.

What to do now

• Do not consume the recalled item if you have a milk allergy or severe sensitivity and your package matches the criteria above.
• Return it to the place of purchase for an exchange or a warning-sticker labeled replacement—following the recall instructions posted by FDA.

Where it was sold—and what to watch next

FDA says the recall applies to specific lots/packages meeting the expiration-date and labeling criteria. For the exact distribution outlets, readers should use the product-specific identifiers in the FDA recall notice. Texas’s health agency also tracks FDA food recalls, which can help you monitor whether additional retailer guidance or updates appear as the recall moves through stores.

Sources

• FDA Recall Notice (Ola-Ola Pounded Yam — undeclared milk/sodium caseinate)
• Texas DSHS food recall tracking

FDA’s notice says the affected product was fraudulently diverted after it was set for destruction and sold into the U.S. marketplace. As of the recall posting, FDA states it has received no related reports of pet illness or injury.

Which PEDIGREE product is affected (check the lot code on the can)

Do not rely on the front label alone. The recall applies to only two lot codes, printed on the bottom of the can:

• 613C3KKCFC
• 613C1KKCFC

If your can matches neither lot code, the recall does not cover it (FDA describes the scope as limited to these two lots).

What risk FDA says is possible

According to the FDA recall notice, the concern is hard/sharp metal and plastic foreign material inside the affected cans. FDA describes potential harm from sharp objects, including choking, lacerations, or gastrointestinal tract blockage if a pet ingests foreign material.

Again, FDA says it has received no related reports of illness or injury as of the recall posting.

What pet owners should do now

If you have cans from either affected lot:

• Stop feeding the recalled lot immediately.
• Check the lot code printed on the bottom of the can.
• Contact PEDIGREE Consumer Care for a replacement, and keep your lot information available.

Hawai‘i Department of Health also posted public-facing recall guidance that repeats the lot-code requirement and explains what residents should do. Public media coverage (including WGCU) has translated the same key steps into plain language for pet owners.

If you already fed the product

If your dog already ate food from one of the recalled lots and you’re worried, FDA advises contacting your veterinarian. Share the lot code and the product name/size so the vet can advise on whether any monitoring or next steps are appropriate.

What to watch next

The practical takeaway is still: verify your can’s lot code, and if it matches, follow the stop-feeding and replacement steps. Keep an eye on any additional updates from FDA and company guidance as the recall process moves forward.

Sources

• FDA recall notice: Voluntary Recall of Two Lots of PEDIGREE Can High Protein Chopped Chicken & Duck Flavor Wet Dog Food (foreign metal/plastic)
• Hawai‘i Department of Health alert: PEDIGREE recall guidance (lot codes + what to do)
• WGCU (public media) explainer on the FDA recall

In the July 6 update, the agencies say the investigation remains open, with 4 reported infant botulism cases and 4 hospitalizations. FDA also says additional testing is underway, with results expected in the coming weeks.

What’s new in the July 6 federal update

CDC and FDA report that four infants in three states (California, Pennsylvania, and Washington) were affected, with illness onset reported between April and May 2026. They also say the investigation is ongoing and that testing is underway on formula associated with the cases.

For context, FDA’s June 26, 2026 update reported three confirmed infant botulism illnesses linked to the same recalled formula. The July 6 update increased the total to four.

Which formula is involved (and what the recall covers)

The update centers on Nara Organics Whole Milk Organic Powdered Infant Formula. FDA’s recall posting says Nara Organics voluntarily recalled all lots of this powdered infant formula due to a potential risk of Clostridium botulinum contamination.

What caregivers should do now

CDC and FDA are consistent on one core step: do not feed infants the recalled formula.

• If you have unopened cans: CDC says to throw them away or return them.
• If you have an opened can: CDC says to take a picture and record the lot number and use-by date. CDC says to consider keeping the formula in case the state health department wants to test it if your infant develops symptoms. If you keep it, write “DO NOT USE” on it, store it away from other items you feed your baby for at least a month, and if no symptoms appear after a month, throw the leftover formula away.

CDC also says to wash items and surfaces that may have touched the recalled formula using hot soapy water or a dishwasher.

Warning signs that require urgent medical care

CDC says infant botulism often starts with constipation and is usually first noticed as difficulty feeding (including trouble sucking and swallowing), a weak or altered cry, and loss of muscle tone.

But CDC’s guidance for immediate medical care is specific. If an infant consumed Nara Organics infant formula and has any of these signs or symptoms, CDC says to seek urgent medical care:

• Poor feeding
• Loss of head control
• Difficulty swallowing
• Decreased facial expression

CDC cautions that symptoms can take as long as several weeks to develop, and advises caregivers to watch for symptoms for a month after the infant last consumed the product.

What to watch next

FDA describes the work as ongoing. Testing is underway, and FDA says it expects to post additional updates as information becomes available. For families, the practical takeaway is to treat this as a time-sensitive safety issue: stop using the recalled formula, follow CDC’s handling steps for unopened versus opened cans, and get urgent medical care if symptoms appear.

Sources

• CDC: Infant botulism outbreak linked to powdered infant formula (July 6, 2026 update)
• FDA: Outbreak investigation of infant botulism linked to powdered infant formula (current update July 6, 2026)

If you or someone in your household is in a higher-risk group—such as people with weakened immune systems or lung diseases—FDA says the affected product presents a reasonable probability that use could cause serious and life-threatening infections, including invasive sinusitis and lung infections.

What was recalled (check the lot code)

FDA says the recalled item is Beekeeper’s Naturals Saline Nasal Spray, sold in a single-unit 1 FL OZ (30 mL) bottle. The FDA notice says the lot number (5950) and expiration date (02/2028) are printed on the bottom or back label.

To identify the affected product, FDA instructs consumers to: check the lot number on the bottom or back label of your bottle. If it reads Lot 5950 (Best By: 02/2028), discontinue use.

FDA also states that no other Beekeeper’s Naturals products—including “Nasal Spray Max”—are impacted by this voluntary recall.

Why FDA is concerned

In its posting, FDA summarizes the company’s reason for the recall: the affected lot tested above acceptable microbiological limits for yeast and may contain Aspergillus spp.

FDA says the company has received four reports from customers regarding adverse reactions potentially related to the recalled product, including sinus congestion, irritation or infection.

Who should be most careful

FDA focuses its higher-risk language on “the population most at risk,” including people with weakened immune systems or lung diseases.

CDC notes that many people breathe in Aspergillus spores without getting sick. But CDC also explains that people with weakened immune systems or lung diseases are at higher risk for developing health problems due to Aspergillus, and that symptoms can range from mild to life-threatening.

CDC lists symptom examples by type, including for allergic Aspergillus sinusitis: stuffiness, runny nose, headache, and reduced ability to smell. For more severe forms such as invasive aspergillosis, CDC lists symptoms that can include fever, chest pain, cough, coughing up blood, and shortness of breath. CDC advises contacting a healthcare provider if you have symptoms you think are related to any form of aspergillosis.

What to do now if you have the spray

FDA’s immediate instructions are straightforward:

• Stop using lot #5950 (Best By: 02/2028).
• Contact Beekeeper’s Naturals at contact@beekeepersnaturals.com or 1-888-759-6910 (Monday–Friday, 8am to 8pm ET) for a refund, or if you have any other questions.
• If you have experienced any problems that may be related to taking or using this product, contact your physician or healthcare provider.

How to report possible side effects to FDA (MedWatch)

FDA says adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by

Sources

• FDA MedWatch: how to report adverse events
• CDC: Aspergillosis signs and symptoms